Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00397111 · ClinicalTrials.gov registry record
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
A clinical trial of Anxiety Disorders and Mood Disorders, sponsored by National Institute of Mental Health (NIMH).
- Recruiting
- Registry status
- 390
- Enrollment target
- 1
- Study location
NCT00397111: Recruiting study of Anxiety Disorders and Mood Disorders, sponsored by National Institute of Mental Health (NIMH).
NCT00397111 is a study of Anxiety Disorders and Mood Disorders that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 390 participants, below the 1,135-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00397111, a study of Anxiety Disorders and Mood Disorders, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).
- RECRUITING
- Registry status
- 390 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is intended to help develop new MRI imaging techniques for studying mood and anxiety disorders. Researchers believe that depression and anxiety disorders may cause structural and functional changes in the brain. This study will optimize the way MRI scans are collected to look at brain structure and examine how the brain behaves while subjects perform particular tasks. Healthy volunteers and individuals with major depressive disorder may be eligible for this study. Participants undergo magnetic resonance imaging (MRI) and neuropsychological testing. : Individuals will be asked to participate in an MRI study on one of several scanners. The scanner used will measure blood flow in the brain, concentrations of certain chemicals in the brain, or magnetic properties of the brain. The scan may involve They watching a screen presenting images or doing a task in which they respond to pictures or sounds. Participants may be asked to return for additional scans. The study also involves neuropsychological tests, which assess cognitive performance. Often, people with mood disorders have subtle changes in performance on these tests that allow researchers to pinpoint where brain abnormalities occur. Before the tests can be used in patients, they must be validated by using healthy subjects. These tests are presented either orally, in written form, or on a computer.
Primary Outcome
Magnetic Resonance Imaging data
Conditions Studied
Interventions
- DEVICE 7T Magnetic Resonance Imaging scanner
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2006-12-06 |
What NCT00397111 shows while recruiting
NCT00397111 is an observational study that tracks outcomes without assigning an intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 1,135-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which 7T Magnetic Resonance Imaging scanner is the first listed.
NCT00397111 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00397111 about?
NCT00397111 is a clinical study titled "Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders". This study is intended to help develop new MRI imaging techniques for studying mood and anxiety disorders. Researchers believe that depression and anxiety disorders may cause structural and functional changes in the brain. This study will optimize the way MRI scans are collected to look at brain str...
What is the current status of trial NCT00397111?
This trial is currently recruiting. The enrollment target is 390 participants. The study started on 2006-12-06.
What conditions does trial NCT00397111 study?
This clinical trial studies the following conditions: Anxiety Disorders, Mood Disorders.
What interventions are being tested in trial NCT00397111?
The interventions under investigation include: 7T Magnetic Resonance Imaging scanner (DEVICE).
Who is sponsoring clinical trial NCT00397111?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00397111 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00397111's enrollment target sits among peer trials
390 16th of 84 higher than 69 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
RECRUITING · Phase 4
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
- NCT05997615 · 390 participants · Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- NCT06132893 · 390 participants · Phase 2
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI